Apple

Sonos faced customer backlash due to a problematic app update, leading to lost trust and sales. The company is investing $20-30 million to fix the app and improve customer support, aiming to regain trust and stabilize finances. Executives have forgone bonuses until the turnaround succeeds.

Apple's Hearing Aid Feature (HAF) for AirPods Pro, approved by the FDA, aids mild to moderate hearing loss in adults. Adjustments for volume, tone, and balance are possible, but it lacks professional fitting and extended use capabilities. Audiologist Deyanira Gonzalez advises consulting professionals for accurate hearing assessments and tailored solutions.

Synchron CEO Dr. Tom Oxley discusses the race for FDA approval of BCI implants, lessons from the Command trial, and the potential for consumer use. Synchron and Neuralink are leading contenders, with Synchron's minimally invasive approach potentially giving it an edge. Oxley emphasizes the importance of safety and interoperability in BCI development, and envisions a future where BCIs could be used for consumer technology, though this is still far off.

Apple plans to release a smart display in 2025 with a new homeOS, based on tvOS and supporting apps like Calendar and Home. The device may feature a wall-mountable design with magnets and introduce new functionalities like Apple Intelligence. References to homeOS in code suggest a more user-friendly experience compared to using an iPad for smart home control.

Opinions on iPhone 16 are mixed; Dan Ives predicts a 'supercycle' for Apple, while others question demand forecasts. Warren Buffett's Berkshire Hathaway reduced its Apple stake, David Shaw's D. E. Shaw sold 33% of its Apple shares, and Steven Cohen's Point72 Asset Management initiated a position in Apple. Despite varying investment strategies, all remain exposed to Apple, viewing it as a potential AI growth opportunity.

Apple Watch Series 10, 9, and Ultra 2 receive FDA and Health Canada approval for sleep apnea detection, leveraging accelerometer data to alert users of potential breathing disturbances, available in over 150 countries this month.

FDA approves dupilumab for COPD, xanomeline and trospium chloride for schizophrenia, levacetylleucine for Niemann-Pick disease type C, FluMist for self-administered flu prevention, benralizumab for eosinophilic granulomatosis with polyangiitis, lebrikizumab-lbkz for atopic dermatitis, OTC hearing aid software for mild to moderate hearing loss, DaylightRX for generalized anxiety disorder, a disposable insulin patch pump for T1D and T2D, and an updated Novavax COVID-19 vaccine.

Internet Explorer is no longer supported by Microsoft; use a supported browser like Google Chrome, Apple Safari, Firefox, or Microsoft Edge.

Meta launched AI chatbots voiced by celebrities like Judi Dench and John Cena, aiming to diversify revenue. CEO Mark Zuckerberg unveiled AR glasses prototypes, hoping to replace smartphones. Meta AI, available on Instagram, Facebook, and WhatsApp, faces EU data protection issues. The company aims to make Meta AI the most used assistant by year-end, despite privacy concerns and competition from Google, Microsoft, and Apple.

India extends import management system for IT hardware until Dec 31, 2024, with new import approvals required from Jan 1, 2025, to promote domestic manufacturing and reduce reliance on foreign suppliers.